These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 19412834)
1. Interaction of a peptide corresponding to the loop domain of the S2 SARS-CoV virus protein with model membranes. Guillén J; De Almeida RF; Prieto M; Villalaín J Mol Membr Biol; 2009 May; 26(4):236-48. PubMed ID: 19412834 [TBL] [Abstract][Full Text] [Related]
3. Structural and dynamic characterization of the interaction of the putative fusion peptide of the S2 SARS-CoV virus protein with lipid membranes. Guillén J; de Almeida RF; Prieto M; Villalaín J J Phys Chem B; 2008 Jun; 112(23):6997-7007. PubMed ID: 18489147 [TBL] [Abstract][Full Text] [Related]
4. Interaction of a peptide from the pre-transmembrane domain of the severe acute respiratory syndrome coronavirus spike protein with phospholipid membranes. Guillén J; Moreno MR; Pérez-Berna AJ; Bernabeu A; Villalaín J J Phys Chem B; 2007 Dec; 111(49):13714-25. PubMed ID: 18020324 [TBL] [Abstract][Full Text] [Related]
5. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors. Liu S; Xiao G; Chen Y; He Y; Niu J; Escalante CR; Xiong H; Farmar J; Debnath AK; Tien P; Jiang S Lancet; 2004 Mar; 363(9413):938-47. PubMed ID: 15043961 [TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein. Sainz B; Rausch JM; Gallaher WR; Garry RF; Wimley WC J Virol; 2005 Jun; 79(11):7195-206. PubMed ID: 15890958 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein. Sainz B; Mossel EC; Gallaher WR; Wimley WC; Peters CJ; Wilson RB; Garry RF Virus Res; 2006 Sep; 120(1-2):146-55. PubMed ID: 16616792 [TBL] [Abstract][Full Text] [Related]
8. Identification of the membrane-active regions of the severe acute respiratory syndrome coronavirus spike membrane glycoprotein using a 16/18-mer peptide scan: implications for the viral fusion mechanism. Guillén J; Pérez-Berná AJ; Moreno MR; Villalaín J J Virol; 2005 Feb; 79(3):1743-52. PubMed ID: 15650199 [TBL] [Abstract][Full Text] [Related]
9. Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide. Madu IG; Roth SL; Belouzard S; Whittaker GR J Virol; 2009 Aug; 83(15):7411-21. PubMed ID: 19439480 [TBL] [Abstract][Full Text] [Related]
10. The aromatic domain of the coronavirus class I viral fusion protein induces membrane permeabilization: putative role during viral entry. Sainz B; Rausch JM; Gallaher WR; Garry RF; Wimley WC Biochemistry; 2005 Jan; 44(3):947-58. PubMed ID: 15654751 [TBL] [Abstract][Full Text] [Related]
11. Membranotropic and biological activities of the membrane fusion peptides from SARS-CoV spike glycoprotein: The importance of the complete internal fusion peptide domain. Basso LGM; Zeraik AE; Felizatti AP; Costa-Filho AJ Biochim Biophys Acta Biomembr; 2021 Nov; 1863(11):183697. PubMed ID: 34274319 [TBL] [Abstract][Full Text] [Related]
12. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. Bosch BJ; van der Zee R; de Haan CA; Rottier PJ J Virol; 2003 Aug; 77(16):8801-11. PubMed ID: 12885899 [TBL] [Abstract][Full Text] [Related]
13. Core structure of S2 from the human coronavirus NL63 spike glycoprotein. Zheng Q; Deng Y; Liu J; van der Hoek L; Berkhout B; Lu M Biochemistry; 2006 Dec; 45(51):15205-15. PubMed ID: 17176042 [TBL] [Abstract][Full Text] [Related]
14. Structural basis for coronavirus-mediated membrane fusion. Crystal structure of mouse hepatitis virus spike protein fusion core. Xu Y; Liu Y; Lou Z; Qin L; Li X; Bai Z; Pang H; Tien P; Gao GF; Rao Z J Biol Chem; 2004 Jul; 279(29):30514-22. PubMed ID: 15123674 [TBL] [Abstract][Full Text] [Related]
15. Membrane insertion of the three main membranotropic sequences from SARS-CoV S2 glycoprotein. Guillén J; Kinnunen PK; Villalaín J Biochim Biophys Acta; 2008 Dec; 1778(12):2765-74. PubMed ID: 18721794 [TBL] [Abstract][Full Text] [Related]
16. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity. Zhu Y; Yu D; Yan H; Chong H; He Y J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627 [TBL] [Abstract][Full Text] [Related]
17. Serine-scanning mutagenesis studies of the C-terminal heptad repeats in the SARS coronavirus S glycoprotein highlight the important role of the short helical region. Follis KE; York J; Nunberg JH Virology; 2005 Oct; 341(1):122-9. PubMed ID: 16081124 [TBL] [Abstract][Full Text] [Related]
18. Structures and polymorphic interactions of two heptad-repeat regions of the SARS virus S2 protein. Deng Y; Liu J; Zheng Q; Yong W; Lu M Structure; 2006 May; 14(5):889-99. PubMed ID: 16698550 [TBL] [Abstract][Full Text] [Related]
19. Spike protein fusion loop controls SARS-CoV-2 fusogenicity and infectivity. Pal D J Struct Biol; 2021 Jun; 213(2):107713. PubMed ID: 33662570 [TBL] [Abstract][Full Text] [Related]
20. The pre-transmembrane region of the HCV E1 envelope glycoprotein: interaction with model membranes. Pérez-Berná AJ; Bernabeu A; Moreno MR; Guillén J; Villalaín J Biochim Biophys Acta; 2008 Oct; 1778(10):2069-80. PubMed ID: 18424260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]